Publications by authors named "Sridevi Addanki"

Claim this Profile
U
Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review.
Sridevi Addanki, Lana Kim, Alexandra Stevens

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA.
Jennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, Roland Bassett, Ekaterina Kalashnikova

BMC Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
Anthony Lucci, Sridevi Addanki, Yi-Ju Chiang, Salyna Meas, Vanessa N Sarli

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer.
Balraj Singh, Vanessa N Sarli, Ryan D Milligan, Hannah E Kinne, Anna Shamsnia, Sridevi Addanki

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
Sridevi Addanki, Salyna Meas, Vanessa Nicole Sarli, Balraj Singh, Anthony Lucci

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.
Suhas V Vasaikar, Abhijeet P Deshmukh, Petra den Hollander, Sridevi Addanki, Nick Allen Kuburich

Br J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
Husna Karaboga, Wentao Huang, Shivangi Srivastava, Scott Widmann, Sridevi Addanki

ACS Chem Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells.
Nicholes R Candelaria, Ryan Weldon, Selvaraj Muthusamy, Trang Nguyen-Vu, Sridevi Addanki

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
Nicholes R Candelaria, Sridevi Addanki, Jine Zheng, Trang Nguyen-Vu, Husna Karaboga

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
Trang Nguyen-Vu, Lise-Lotte Vedin, Ka Liu, Philip Jonsson, Jean Z Lin, Sridevi Addanki

Breast Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis